Metabolomics

Dataset Information

0

Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia


ABSTRACT: Familial dysautonomia (FD) is a rare genetic neurologic disorder caused by impaired neuronal development and progressive degeneration of both the peripheral and central nervous systems. FD is monogenic, with >99.4% of patients sharing an identical point mutation in the elongator acetyltransferase complex subunit 1 (ELP1) gene, providing a relatively simple genetic background in which to identify modifiable factors that influence pathology. Gastrointestinal symptoms and metabolic deficits are common among FD patients, which supports the hypothesis that the gut microbiome and metabolome are altered and dysfunctional compared to healthy individuals. Here we show significant differences in gut microbiome composition (16 S rRNA gene sequencing of stool samples) and NMR-based stool and serum metabolomes between a cohort of FD patients (~14% of patients worldwide) and their cohabitating, healthy relatives. We show that key observations in human subjects are recapitulated in a neuron-specific Elp1-deficient mouse model, and that cohousing mutant and littermate control mice ameliorates gut microbiome dysbiosis, improves deficits in gut transit, and reduces disease severity. Our results provide evidence that neurologic deficits in FD alter the structure and function of the gut microbiome, which shifts overall host metabolism to perpetuate further neurodegeneration.

INSTRUMENT(S): Nuclear Magnetic Resonance (NMR) -

SUBMITTER: Alexandra Cheney  Stephanann Costello  Jesse Peach 

PROVIDER: MTBLS5138 | MetaboLights | 2022-12-06

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
MTBLS5138 Other
FILES Other
a_MTBLS5138_NMR_human_serum_metabolite_profiling.txt Txt
a_MTBLS5138_NMR_human_stool_metabolite_profiling.txt Txt
a_MTBLS5138_NMR_mouse_stool_metabolite_profiling.txt Txt
Items per page:
1 - 5 of 11
altmetric image

Publications


Familial dysautonomia (FD) is a rare genetic neurologic disorder caused by impaired neuronal development and progressive degeneration of both the peripheral and central nervous systems. FD is monogenic, with >99.4% of patients sharing an identical point mutation in the elongator acetyltransferase complex subunit 1 (ELP1) gene, providing a relatively simple genetic background in which to identify modifiable factors that influence pathology. Gastrointestinal symptoms and metabolic deficits are com  ...[more]

Similar Datasets

2019-08-30 | GSE132236 | GEO
2012-03-19 | E-GEOD-31075 | biostudies-arrayexpress
2022-11-01 | GSE200025 | GEO
2020-02-18 | GSE108809 | GEO
2023-03-02 | GSE225983 | GEO
2022-02-01 | E-MTAB-10160 | biostudies-arrayexpress
2016-08-01 | E-GEOD-76590 | biostudies-arrayexpress
2023-01-18 | PXD038906 | Pride
2020-12-14 | PXD023099 |
2012-03-19 | GSE31075 | GEO